NCT00785044View on ClinicalTrials.gov

Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

CompletedOBSERVATIONAL
Enrollment

471

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

February 28, 2010

Conditions
Congestive Heart Failure
Interventions
DRUG

I-123 mIBG

This was an observational study. Participants were previously dosed in separate study.

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY

NCT00785044 - Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event | Biotech Hunter | Biotech Hunter